The development of a large prostate is an unavoidable element of getting older for the majority of men. This condition, known as BPH, affects as many as half the men aged 50 or older. By age 85, this percentage gets up to nearly 90%. However, when BPH is the cause, an enlarged prostate is neither life-threatening nor cancerous. Regardless, living with an enlarged prostate can be quite uncomfortable. It can also be inconvenient, as it can increase the frequency with which you need to urinate. It can also make it take longer to properly drain the bladder.

There are a number of treatments for this condition that all aim to reduce or eliminate swollen prostate tissues.

Urolift and Rezum vs. PAE for Treating BPH

Urolift is a minimally invasive treatment option for BPH that was designed for smaller prostates, about 40 grams or less. This procedure takes less than an hour, and only mild sedation is required. Tiny implants are placed through the urethra to hold the enlarged prostate tissue out of the way and keep it from compressing the urethra. The risk of sexual side effects is low, and ejaculatory function is usually preserved. However, in Dr. Shusterman's experience symptoms often return after UroLift, so our practice now rarely recommends it.

Rezūm Therapy is an in-office procedure that can be completed in a single appointment. Each vapor injection takes approximately 9 seconds, and the procedure involves the injection of sterile water vapor into the prostate tissue. When the steam contacts the prostate, the energy stored within is released into the prostate. The amount of treatment required will be determined by your doctor and how swollen your prostate has become. Your body’s natural healing process will absorb the treated tissue, resulting in the prostate shrinking. This allows the urethra to open and eases symptoms of BPH. Relief is often experienced within two weeks of receiving treatment. It can require up to three months for the full effects to be felt.

To discuss your symptoms and care options, request a consultation with the 1Prostate team.

Prostatic artery embolization (PAE) is a newer form of minimally invasive treatment that works to improve symptoms of BPH. It is performed in a single visit and involves the placement of microscopic particles to block blood flow to the most affected portions of the prostate. It’s performed by a specialist known as an interventional radiologist (IR). Preventing the blood from reaching the affected areas of the prostate leads to it shrinking, reducing symptoms.

Which Is The Best Treatment For BPH?

UroLift was designed for smaller prostates, about 40 grams or less, without an obstructing middle lobe, and in Dr. Shusterman’s experience symptoms often return, so our practice now rarely recommends it. PAE is our first-line procedure: it is the least invasive option with the fewest complications, usually needs no catheter, and works for larger prostates too, including glands over 80 to 100 grams, although some men may need retreatment. Rezum, studied mainly in prostates of about 30 to 80 mL, is our alternative when PAE isn’t the right fit. The outcomes of each procedure will vary from patient to patient. Speak to your urologist and interventional radiologist to determine which approach is best suited for your case.

Sources

  1. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026). American Urological Association, 2026.
  2. EAU Guidelines on the Management of Non-neurogenic Male LUTS. European Association of Urology, 2026.
  3. Society of Interventional Radiology (SIR) 2026 Practice Guidance Document for Prostatic Artery Embolization. J Vasc Interv Radiol, 2026.
  4. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol, 2013.
  5. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis, 2019.
  6. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol, 2021.
  7. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia. Eur Urol, 2020.

Share this blog!

Facebook Twitter LinkedIn

Recent Post

Stay hydrated. Cropped shot of a handsome young male athlete hydrating during his workout on the beach.

Managing Chronic Prostatitis: Natural Remedies That Help

Read More » Turmeric (curcumin) powder and fresh rhizome with turmeric plant background.

The Role of Curcumin in Prostate Health

Read More » Obesity and Prostate Cancer

How Obesity Impacts Prostate Cancer Risk

Read More »